A Wilkins
Overview
Explore the profile of A Wilkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
946
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilkins A, Hall E, Lewis R, Gribble H, Melcher A, Huddart R
Clin Oncol (R Coll Radiol)
. 2022 Jan;
34(7):421-425.
PMID: 34998656
No abstract available.
2.
Wilkins A, Ost P, Sundahl N
Clin Oncol (R Coll Radiol)
. 2021 Mar;
33(6):407-414.
PMID: 33726945
Immune checkpoint inhibitors have transformed the management of patients with metastatic urothelial cancer, by leading to long-term response and prolongation of survival in a subset of patients. Unfortunately, only one...
3.
Hares K, Kemp K, Loveless S, Rice C, Scolding N, Tallantyre E, et al.
J Neurol
. 2021 Jan;
268(6):2175-2184.
PMID: 33484325
There is increasing interest in the development of multiple sclerosis (MS) biomarkers that reflect central nervous system tissue injury to determine prognosis. We aimed to assess the prognostic value of...
4.
Glucocorticoid and inflammatory reactivity to a repeated physiological stressor in insomnia disorder
Devine J, Bertisch S, Yang H, Scott-Sutherland J, Wilkins A, Molina V, et al.
Neurobiol Sleep Circadian Rhythms
. 2019 Jun;
6:77-84.
PMID: 31236523
Despite known associations of insomnia disorder with alterations in cytokine and glucocorticoid (GC) production, neither the sensitivity of immune cells to a GC signal nor the reactivity of the hypothalamus-pituitary-adrenal...
5.
Science in Focus: Biological Optimisation of Radiotherapy Fraction Size in an Era of Immune Oncology
Wilkins A, Melcher A, Somaiah N
Clin Oncol (R Coll Radiol)
. 2018 Jul;
30(10):605-608.
PMID: 30041845
No abstract available.
6.
Ibitoye R, Wilkins A, Scolding N
J Neurol
. 2016 Nov;
264(5):1023-1028.
PMID: 27878437
Sarcoidosis is a rare but important cause of neurological morbidity, and neurological symptoms often herald the diagnosis. Our understanding of neurosarcoidosis has evolved from early descriptions of a uveoparotid fever...
7.
Hares K, Redondo J, Kemp K, Rice C, Scolding N, Wilkins A
Neuropathol Appl Neurobiol
. 2016 Jan;
43(3):227-241.
PMID: 26785938
Aims: Understanding the causes of axonal pathology remains a key goal in the pursuit of new therapies to target disease progression in multiple sclerosis (MS). Anterograde axonal transport of many...
8.
Hornby S, McDermott F, Coleman M, Ahmed Z, Bunni J, Bunting D, et al.
Ann R Coll Surg Engl
. 2015 Feb;
97(2):115-9.
PMID: 25723687
Background: Laparoscopic hernia repair is used widely for the repair of incisional hernias. Few case studies have focussed on purely 'incisional' hernias. This multicentre series represents a collaborative effort and...
9.
Hares K, Kemp K, Rice C, Gray E, Scolding N, Wilkins A
Mult Scler
. 2013 Oct;
20(7):812-21.
PMID: 24144874
Background: Multiple sclerosis (MS) is a neurological disease characterised by central nervous system inflammation, demyelination, axonal degeneration and neuronal injury. Preventing neuronal and axon damage is of paramount importance in...
10.
Rice C, Sun M, Kemp K, Gray E, Wilkins A, Scolding N
Eur J Neurosci
. 2012 Jun;
35(12):1887-93.
PMID: 22708600
Given the significant socioeconomic impact of progressive multiple sclerosis (MS) and the paucity of treatment options, there is an urgent need to develop new and effective therapies for this disabling...